Yu Fujita

22PUBLICATIONS
76CO-AUTHORS
Haematological tumoursMedical virologyIndustrial molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 11, 2026
Author Correction: The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.

|Jan 29, 2026
Updating MISEV: When, What, How, and Why?

Naveed Akbar, Dylan Burger, Benedetta Bussolati

|Jan 14, 2026
From Lab to Industry: Advancing the Translational Potential of Extracellular Vesicles Through the ISEV Translation, Regulation and Advocacy Committee (ISEV-TRA).

Uxia Gurriaran-Rodriguez, Benedetta Bussolati, Mario Gimona

|Feb 07, 2025
Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-I production following viral infection.

Trever T Greene, Yeara Jo, Carolina Chiale

|Jun 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.

Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata

|May 06, 2024
Mitigation of acute lung injury by human bronchial epithelial cell-derived extracellular vesicles via ANXA1-mediated FPR signaling.

Yu Fujita, Tsukasa Kadota, Reika Kaneko

Pageof 4

Frequent Collaborators

9 joint publications

Tsukasa Kadota

4 joint publications

Shunsuke Minagawa

4 joint publications

Nayuta Saito

4 joint publications

Takanori Numata